| |
| Research Programs |
| |
|
:: Laboratory :: References :: |
|
|
CURRENT RESEARCH PROGRAMS
| TITLE |
DURATION |
SOURCE |
|
|
|
| • ERA-NET Parasite and host genetic diversity in Helicobacter infections |
2007-2010 |
European Community
14,656 € |
| • Qualitative determination of viral load in the serum of patients with chronic Hepatitis C infection |
2005-2007 |
Schering-Plough
45,000 € |
| • Quantitative determination of viral load and/or viral genotype in the serum of patients with chronic Hepatitis C infection |
|
Schering-Plough
160,000 € |
| • ACIP Etude de la fréquence de l'infection par Helicobacter pylori (Hp) des patients présentant une pathologie gastro-duodénale, de la sensibilité des souches aux antibiotiques et de la diversité de la région 3’ du gène cagA. |
2007-2008 |
Institut Pasteur Paris
8,214 € |
| • CagA motogenic effects induced on gastric epithelial cells upon H. pylori infection in vitro. Study on the interaction of CagA with PLC and effect on intracellular Ca2+ levels. |
2004-2006 |
Hellenic Pasteur Institute
13,500 € |
PAST RESEARCH PROGRAMS
| TITLE |
DURATION |
SOURCE |
|
|
|
| • PROPATH Molecular analysis and mechanistic elucidation of the functionality of pro- and prebiotics in the inhibition of pathogenic micro-organisms to combat gastrointestinal disorders and to improve human health |
2001-2004 |
EU 5TH Framework program
264,124 € |
| • British Council Epidemiology and guidelines for the control of pathogens Campylobacter and Salmonella in the poultry industry |
2001-2002 |
British Council
4,500 € |
| • PAVET – LAVIPHARM. Study of biologically active substances with potential antimicrobial and healing activity isolated from traditional plant origin |
2001-2003 |
GSRT*
14,674 € |
| • Development of new type of yogurt with probiotic properties – Effect on health (Program 97 DIATRO-26) Coordinator: Α. Mentis |
1999-2001 |
GSRT* |
| • European multi-center study to monitor antibiotic resistance to H pylori in children |
2000-2001 |
ΕU |
| • Relationship of gastric cancer to diet and H. pylori status |
1999-2001 |
Pasteur Institute Greece |
| • 1998 Εuropean Multicenter in vitro study on antimicrobial resistance in H. pylori |
1998-1999 |
ΕU |
| • Incidence of Escherichia coli virulent strains in food specimens. Detection of virulence factors. |
1998-1999 |
Institute Pasteur,France |
| • cagA και vacA subtypes of H. pylori clinical strains in the child population with gastritis |
1998-1999 |
Hellenic Ministry of Health |
| • Development of immunodiagnostic kits for antidody detection of CMV, Toxoplasma, Rubella and Helicobacter pylori. |
1998-1999 |
GSRT* |
| • Development of health services provided by the Diagnostic and Vaccines Quality Control Section of Hellenic Pasteur Institute to the industry |
1998-2000 |
GSRT* |
| • Early inhibition of sepsis: Development of methods controlling molecular mechanisms of signal transduction via tyrosine kinases and reactive oxidative substances. |
1999-2000 |
GSRT* |
| • Eurohepygast: Evolution of the stomach with chronic gastritis with a particular emphasis on disease markers for peptic ulcer and premalignant conditions |
1997-1999 |
BIOMED I (ΕU) |
| • European research network on congenital toxoplasmosis, Working group on Standardisation and quality assurance |
1997-1999 |
ΒIOMED Ι (ΕU) |
*GSRT: General Secretariat for Research and Technology, Greek Ministry of Development
|
|
|
|
|
|
|
|